Compare AKBA & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKBA | BBSI |
|---|---|---|
| Founded | 2007 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.1M | 711.6M |
| IPO Year | 2014 | 1994 |
| Metric | AKBA | BBSI |
|---|---|---|
| Price | $1.24 | $27.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $5.75 | ★ $42.67 |
| AVG Volume (30 Days) | ★ 3.4M | 246.1K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.15% |
| EPS Growth | ★ 93.94 | 5.05 |
| EPS | N/A | ★ 2.08 |
| Revenue | N/A | ★ $920,432,000.00 |
| Revenue This Year | $17.63 | $9.89 |
| Revenue Next Year | N/A | $5.58 |
| P/E Ratio | ★ N/A | $13.38 |
| Revenue Growth | N/A | ★ 9.50 |
| 52 Week Low | $1.14 | $25.33 |
| 52 Week High | $4.08 | $49.65 |
| Indicator | AKBA | BBSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.07 | 26.88 |
| Support Level | $1.14 | N/A |
| Resistance Level | $1.57 | $37.80 |
| Average True Range (ATR) | 0.10 | 1.60 |
| MACD | 0.01 | -0.49 |
| Stochastic Oscillator | 18.48 | 22.58 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.
Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.